Epidemiological Description of the Kaposi's Disease in France's Southeast

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03662828

Acronym

KAPOSI-1

Enrollment

100

Registered

2018-09-10

Start date

2018-08-01

Completion date

2020-08-31

Last updated

2019-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kaposi's Disease

Keywords

Kaposi's disease, HHV8, Prevalence

Brief summary

The purpose of this study is to evaluate the prevalence of the Kaposi's disease in France's southeast on 10 years (from 2007 to 2017)

Detailed description

Kaposi's disease is a multifocal disease with cutaneous expression in more than 95% of cases. There are 4 forms : Mediterranean, Endemic (Sub-Saharan Africa), iatrogenic and epidemic (HIV) The physiological hypotheses to explain the disease are not clear. A proliferation of immunity cells in blood vessels and also an undetermined role of the human herpes virus 8 (HHV-8) could be involved. The treatment is complex and not standardized. There are a lot of different treatments. The purpose of this study is to evaluate the prevalence and described the characteristics and the treatment of the Kaposi's disease in the France's southeast on 10 years, from 2007 to 2017.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosed patients with a Kaposi's disease by biopsy from January 2007 to December 2017

Exclusion criteria

* Opposition to the use of personal data

Design outcomes

Primary

Measure	Time frame	Description
Prevalence of Kaposi's disease	10 years (2007-2017)	Diagnosed patients with biopsy, in France's southeast

Secondary

Measure	Time frame	Description
Descriptive analysis of the population : sociodemographic	10 years (2007-2017)	sociodemographic characteristics
Descriptive analysis of the population : paraclinical	10 years (2007-2017)	paraclinical characteristics
Descriptive analysis of the different form of the Kaposi's disease in the population	10 years (2007-2017)	Mediterranean form, endemic form, iatrogenic form and epidemic form
Descriptive analysis of the population : therapeutic	10 years (2007-2017)	therapeutic care
Survival analysis	10 years (2007-2017)	mortality rate
Descriptive analysis of the population : clinical	10 years (2007-2017)	clinical characteristics

Countries

France

Outcome results